Intec Pharma (XTAE:NTEC) Net Interest Income : ₪0.25 Mil (TTM As of Mar. 2021)

View and export this data going back to 2010. Start your Free Trial

What is Intec Pharma Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Intec Pharma's net interest income for the three months ended in Mar. 2021 was ₪-0.12 Mil. Its net interest income for the trailing twelve months (TTM) ended in Mar. 2021 was ₪0.25 Mil.

Intec Pharma Net Interest Income Historical Data

The historical data trend for Intec Pharma's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intec Pharma Net Interest Income Chart

Intec Pharma Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Net Interest Income

Get a 7-Day Free Trial

0.60

1.00

3.09

1.17

0.11

Intec Pharma Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
Net Interest Income	Get a 7-Day Free Trial															-0.26	0.02	-0.21	0.57	-0.12

Intec Pharma Net Interest Income Calculation

Net Interest Income for the trailing twelve months (TTM) ended in Mar. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪0.25 Mil.

Intec Pharma Net Interest Income Related Terms

Thank you for viewing the detailed overview of Intec Pharma's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Intec Pharma (XTAE:NTEC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intec Pharma Ltd (XTAE:NTEC) » Definitions » Net Interest Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

12 Hartom Street, Har Hotzvim, Jerusalem, ISR, 9777512

Website

https://www.intecpharma.com

Intec Parent Inc, formerly Intec Pharma Ltd is a clinical-stage biopharmaceutical company based in Israel. The company is focused on research and development and clinical trials. The company develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing efficient gastric retention. Accordion Pill Carbidopa/Levodopa or AP-CDLD is being developed by the company for the indication of treatment of Parkinson's disease.